Easing PPE demands | Vaccines and kids | Antiviral therapeutics
“The art of life is a constant readjustment to our surroundings." — Okakura Kakuzō, Japanese scholar
April 14, 2021
NAVIGATING THE RECOVERY
Image by Memory Stockphoto for Shutterstock
Easing PPE demands
National Personal Protective Technology Laboratory in Pittsburgh--which has been developing a new kind of respirator that would ease demand for N95s masks during the pandemic--has received a $14 million grant from the U.S. Department of Health.
Double lung transplant on COVID patient
In December, surgeons at OSU’s Wexner Medical Center Comprehensive Transplant Center successfully performed a lifesaving double lung transplant on a patient who recovered from COVID-19. Since then, they have performed three more lung transplants.
Vaccines and kids
Cincinnati Children’s is now testing Pfizer’s COVID-19 vaccine in children between the ages of five and 11, with a focus currently on getting the dosage right.
Sanitizing vending machines
An Iowa company has developed new sanitation tech: UV vending machines. The machines use UV rays but include safeguards such as a shielding that directs radiation to target surfaces and a shut off mechanism for when a consumer approaches the machine.
Minneapolis-based Bio-Techne Corporation today announced that its R&D Systems and Novus brands have been named winners of the CiteAb COVID-19 Innovation Award for its products that helped shape the life sciences sectors understanding of, or resilience to, COVID-19.
Phytoption LLC, a startup in the Purdue Research Park, is looking for partners to help advance the development of antiviral therapeutics it says could fight against COVID-19 and other viral diseases.
Share these stories!
PUDDLE HOPS: HEALTH TECH
Flyover Future has followed medical and tech news around COVID-19 from the beginning of the pandemic. We're adding coverage to this report related to health care innovation to feature more advances across Flyover Country.
Share these stories!
Share stories, offer suggestions, or comment!